Yaoyanshe won ¥300m in a C round of financing co-led by Eastern bell Capital and Sequoia China

Pharmaceutical R&D SaaS platform “Yaoyanshe” completed ¥300m in a C round of financing co-led by Eastern bell Capital and Sequoia China and followed by Matrix Partners, Vision Capital, and Genesis Capital. This round of financing will mainly be used for the company’s core barriers construction.

Founded in 2015, Yaoyanshe focuses on providing a technology platform of innovative Pharmaceutical R&D service for pharmaceutical enterprises, establishing standardization and process of pharmaceutical R&D service through science and technology, and providing pharmaceutical enterprises with innovative and efficient pharmaceutical R&D supply chain service.